Codeine-Guaifenesin
- Product NDC
- 68071-5173
- 11-digit product format
- 680715173
- Labeler code
- 68071
- Product ID
- 68071-5173_1b56a7bc-e859-d8c7-e063-6294a90a5ee1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Codeine Phosphate and Guaifenesin
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-04-01
- Substance
- CODEINE PHOSPHATE; GUAIFENESIN
- Active strength
- 10; 100 mg/5mL; mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 68071-5173-4 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 68071-5173-4 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 68071-5173-4 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Codeine-Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 10 mg/5mL |
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| GSL05Y1MN6 | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995868 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9e691264-d48a-6b48-e053-2995a90a9352 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-5173-4 | 2024-06-25 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
| 68071-5173-4 | 2023-01-30 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5173-4 | Codeine-Guaifenesin | 120 mL in 1 BOTTLE | SOLUTION | 120 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5173 | CODEINE-GUAIFENESIN (CODEINE PHOSPHATE AND GUAIFENESIN) SOLUTION [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240627_9e691264-d48a-6b48-e053-2995a90a9352.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | A-S Medication Solutions | 92559d65-f5e2-4054-9763-b9c560452dab | 2026-05-22 | Warnings | M013 |
| Acetaminophen PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Grocery Outlet, Inc. | 441d2629-3fff-0bf1-e063-6394a90aa9b6 | 2026-05-21 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Grocery Outlet, Inc. | 441d1bde-d677-fab7-e063-6394a90aaad4 | 2026-05-21 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Grocery Outlet, Inc. | 441d3a39-cc55-3c7c-e063-6394a90ad7a7 | 2026-05-21 | Warnings | M013 |
| INFANTS Pain and Fever | ACETAMINOPHEN | Aurohealth LLC | b3f57af5-661f-4534-9eed-76e431f338db | 2026-05-20 | Warnings | M013 |
| Good Sense aspirin | ASPIRIN | L. Perrigo Company | e150dd59-8db8-449f-9c9a-1aa6deb3be2e | 2026-05-20 | Warnings | M013 |
| Infants Pain and Fever | ACETAMINOPHEN | Aurohealth LLC | e837538d-0515-4f99-b04c-fda63b28777e | 2026-05-20 | Warnings | M013 |
| Walgreens Headache Relief Extra Strength | ACETAMINOPHEN 250MG, ASPIRIN 250MG AND CAFFEINE 65MG | Walgreens | 52109b65-3bf1-de38-e063-6394a90a9727 | 2026-05-18 | Warnings | M013 |
| Genexa Infants Pain and Fever | ACETAMINOPHEN | Genexa Inc. | 5220a40d-4a4f-5bad-e063-6394a90a93b0 | 2026-05-18 | Warnings | M013 |
| childrens Pain and Fever | ACETAMINOPHEN | Topco Associates, LLC | 7f7b4377-9b40-4a12-808b-f1cd7d241b0d | 2026-05-18 | Warnings | M013 |
| Aspirin Enteric Coated, Regular Strength | ASPIRIN | Gendose Pharmaceuticals, LLC | 10b9a1fc-70d1-44ea-a6de-5c1943e8fbaa | 2026-05-15 | Warnings | M013 |
| Aspirin | ASPIRIN | Gendose Pharmaceuticals, LLC | 119de26f-cce5-401c-81fa-775ebebf6c6f | 2026-05-15 | Warnings | M013 |
| Aspirin Low Dose Chewable Orange | ASPIRIN | Cardinal Health 107, LLC | 827bbe77-febb-4352-892f-3fbb2acfc7d5 | 2026-05-14 | Warnings | M013 |
| Aspirin | ASPIRIN | Topco Associates, LLC | 56c125de-fabf-41fa-88a4-760d2793f202 | 2026-05-13 | Warnings | M013 |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Chain Drug Marketing Association, Inc. | 17216bf3-bed0-4d7a-994e-76a0e4c79c5c | 2026-05-13 | Warnings | M013 |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | A-S Medication Solutions | c445c6bb-69a8-492e-b100-ce942707f203 | 2026-05-12 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | Valu Merchandisers Company | 1754a9f2-e7e5-4efb-a728-6ba2a7155d11 | 2026-05-12 | Warnings | M013 |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | Target Corporation | bc65e205-64fd-4764-8c5e-2793af4e9adf | 2026-05-12 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | DOLGENCORP, LLC | a7e27000-a26b-46c2-823e-663f4e76db74 | 2026-05-11 | Warnings | M013 |
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995868 | codeine phosphate 10 MG / guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 10 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-5173-4 | 68071517304 | 120 mL in 1 BOTTLE (68071-5173-4) | 120 ml | 2020-02-12 | 0000-00-00 | No | No | Current |